About Jaap Goudsmit, M.D., Ph.D.
Form D filings for RenBio in 2024 list Jaap Goudsmit, M.D., Ph.D. as director.
Jaap Goudsmit, M.D., Ph.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jaap Goudsmit, M.D., Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jaap Goudsmit, M.D., Ph.D. works with at each company, as listed on that company's latest Form D.
RenBio, Inc. · Form D, Sep 6, 2024
RD
Rachel Liberatore, Ph.D.
President and Chief Scientific Officer, director
ZD
Zhi Hong, Ph.D.
Director
DT
Donald Tang
Director
AR
Annelyn O'Rourke
Executive officer
WS
Walter Wang, Sr.
Director